"Minimally invasive surgery is becoming increasingly popular due to its benefits for both patients and healthcare providers."
NovaBone Products, a leader in synthetic bone graft technology, is proud to announce the launch of its new MIS Delivery System with Tip. This innovative system is designed to offer surgeons superior control and reliability in the delivery of bone graft substitutes, specifically tailored for minimally invasive surgical (MIS)procedures.
The MIS Delivery System with Tip is engineered to backfill empty spaces as small as 3.5mm in diameter,ensuring precise placement and optimal outcomes. Its unique conical tip accessory provides surgeons with a choice for superior precision while maintaining exceptional handling through consistent and smooth putty flow. The system is available in multiple configurations, including the MIS Putty System with Tip (10cc) and the MIS Dispenser with Tip.
Carolin Archibald, CEO of NovaBone, expressed her enthusiasm for the new product:"Minimally invasive surgery is becoming increasingly popular due to its benefits for both patients and healthcare providers. Our new MIS Delivery System with Tip elegantly delivers our proven NovaBone Putty through a conical metal tip, ensuring easy handling and precise extrusion. This product reinforces our commitment to providing innovative solutions that improve patient outcomes and support surgeons in their practices."
The NovaBone MIS Delivery System with Tip is currently available in the U.S. market and is pending clearance for use in the interbody space. It will be showcased at the upcoming North American Spine Society (NASS) Annual Meeting on September 25-27 in Chicago, where NovaBone will have a dedicated room to demonstrate the product's capabilities.
Colleen Friedman, Vice President of Orthopedic Sales at NovaBone, added:"We are excited to present the MIS Delivery System with Tip at the NASS Annual Meeting. This system offersa new level of control and precision for orthopedic surgeons, ensuring reliable fusion outcomes with our bioactive bone graft materials. Surgeons attending the conference can visit our booth 5003 to learn more about how this product can enhance their surgical procedures."
The MIS Delivery System with Tip continues NovaBone's legacy of innovation in bone graft substitutes. With over 20 years of experience and more than two million successful implantations, NovaBone's bioactive synthetic formulas are clinically proven to promote osteogenesis, ensuring reliable and accelerated bone growth.
For more information on the new MIS Delivery System with Tip or to schedule a meeting at the NASS conference.
About NovaBone
NovaBone, a Halma company, is privately held and based in Florida since 2002. NovaBone developed the first bioactive synthetic bone graft offered to the orthopedic community and has long been at the forefront of bioactive glass bone graft devices. It has developed numerous formulations and delivery systems of its patented, bioactive technology platform that results in accelerated bone growth. In total, their exclusively formulated bone graft substitute has been used for the repair of osseous defects throughout the skeletal system for over a decade and used in over a million clinical applications with unparalleled success validating the safety and efficacy of NovaBone's technology.
